The impact of codeine rescheduling on non-opioid analgesic use by people who regularly use codeine: a prospective cohort study
International Journal of Clinical Pharmacy · 2024
DOI: 10.1007/s11096-024-01751-9 ↗Kurz gefasst
Kohortenstudie in der Zeitschrift International Journal of Clinical Pharmacy, 2024. Verfasst von Jessie Maher und 3 weiteren Autor:innen. Beteiligte Einrichtung: School of Medicine, The University of Notre Dame Sydney, Chippendale, Australia. Hauptthemen laut MEDLINE: Codeine, Nonprescription Drugs, Analgesics, Non-Narcotic, Acetaminophen. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: University of Tasmania, Monash University.
Abstract (Originalsprache)
Background
Codeine was rescheduled in Australia to prescription only in February 2018. Initial studies reported an increase in population level paracetamol and ibuprofen sales following codeine upscheduling. However, to date no study has been able to investigate changes in non-opioid analgesic use at the individual patient level to determine if sales data reflect actual consumption patterns.
Aim
To address this gap, we aimed to determine the impact of codeine rescheduling on non-opioid analgesic use in people who regularly used over-the-counter codeine, primarily for pain, prior to the rescheduling change.
Method
We conducted a prospective cohort study with 260 participants who reported regular over-the-counter codeine consumption at cohort entry. Surveys were completed at baseline (November 2017, 3 months before rescheduling) and at 1 month (February 2018), 4 months (June 2018), and 12 months (February 2019), following rescheduling. The primary outcomes were mean daily doses of non-opioid analgesics, captured through a 7 day medication diary.
Results
The mean daily paracetamol dose decreased from 1754.4 mg (95% CI 1300.5–2208.3) at baseline to 1023.8 mg (95% CI 808.5–1239.1) at the final time-point (+ 12 months) ( p = .009). The mean daily ibuprofen dose decreased from 305.1mg (95% CI 217.9–392.4) at baseline to 161.2 mg (95% CI 98.5–224.0) 12 months after rescheduling ( p = .03). No significant change in doses of other medications remained was found.
Conclusion
In people who regularly consumed over-the-counter codeine, doses of non-opioid analgesics either reduced or remained stable following codeine rescheduling, suggesting concerns of medication substitution or overuse following the change were not realised.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- School of Medicine, The University of Notre Dame Sydney, Chippendale, Australia.
- School of Psychology, The University of Tasmania, Sydney, Australia.
- Monash Addiction Research Centre, Eastern Health Clinical School, Monash University, Peninsula Campus, Rm 205A, Level, 2, Building D, 47-49 Moorooduc Hwy, Frankston, VIC, 3199, Australia. suzanne.nielsen@monash.edu.
Förderung
- University of Tasmania
- Monash University
Zitieren
APA
Maher, J., McCoy, J., Bruno, R., & Nielsen, S. (2024). The impact of codeine rescheduling on non-opioid analgesic use by people who regularly use codeine: a prospective cohort study. International Journal of Clinical Pharmacy. https://doi.org/10.1007/s11096-024-01751-9
Vancouver
Maher J, McCoy J, Bruno R, Nielsen S. The impact of codeine rescheduling on non-opioid analgesic use by people who regularly use codeine: a prospective cohort study. International Journal of Clinical Pharmacy. 2024. doi:10.1007/s11096-024-01751-9
BibTeX
@article{Maher2024,
author = {Maher, Jessie and McCoy, Jacqui and Bruno, Raimondo and Nielsen, Suzanne},
title = {The impact of codeine rescheduling on non-opioid analgesic use by people who regularly use codeine: a prospective cohort study},
journal = {International Journal of Clinical Pharmacy},
year = {2024},
doi = {10.1007/s11096-024-01751-9}
}
EUVIMED